Omega Diagnostics Group Plc (LON:ODX) had its price objective lifted by FinnCap from GBX 28 ($0.36) to GBX 30 ($0.39) in a report released on Friday, June 30th. They currently have a corporate rating on the stock.
Shares of Omega Diagnostics Group Plc (ODX) remained flat at GBX 18.12 during trading on Friday. 20,620 shares of the company’s stock were exchanged. The stock’s 50-day moving average price is GBX 19.81 and its 200 day moving average price is GBX 20.86. Omega Diagnostics Group Plc has a 12 month low of GBX 15.75 and a 12 month high of GBX 28.01. The stock’s market cap is GBX 19.71 million.
COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this piece of content on another website, it was copied illegally and reposted in violation of US and international trademark and copyright legislation. The original version of this piece of content can be read at https://www.chaffeybreeze.com/2017/07/30/finncap-boosts-omega-diagnostics-group-plc-odx-price-target-to-gbx-30-updated-updated-updated.html.
About Omega Diagnostics Group Plc
Omega Diagnostics Group PLC is a medical diagnostics company. The Company’s segments are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. Its product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers.
Receive News & Ratings for Omega Diagnostics Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Diagnostics Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.